Надсилання статей

Вже маєте Ім'я користувача/Пароль для видання Львівський медичний часопис / Acta Medica Leopoliensia?
Увійдіть на сайт

Потрібні Ім'я користувача/Пароль?

Для того, щоб мати можливість подавати статті до журналу та перевіряти поточний статус своїх подань необхідно увійти на сайт як зареєстрований користувач.


Керівництва для авторів

The editorial board of Lviv Medical Journal / Acta Medica Leopoliensia would like to advise authors submitting articles that they must comply with the following requirements, which are in conformity with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (Am Intern Med 1997, 126, 36-47) of the International Committee of Medical Journal Editors (www.icmje.org).

The Journal accepts original articles, review articles, and other materials, in Ukrainian or English, that have not been previously published in print or electronic form and have not been submitted to another journal. Articles must be approved by all authors. All published articles become the copyright of Danylo Halytsky Lviv National Medical University. The scientific validity of the article is evaluated by the Editorial Board and independent reviewers. The review process is conducted in a double-blind fashion; both the authors and reviewers remain anonymous. The decision to publish a particular article rests with the editorial board. One copy of the manuscript is returned to the author if the paper is rejected.

Preparation of the manuscript

1. Title Page

The first page should include: title of the article (no abbreviations), authors names, affiliations, degrees, the names and initials of department heads, and where the work was performed.

2. Abstract

A structured abstract of no more than 300 words with four sections is required: Purpose, Methods, Results, and Conclusions. The abstract should be followed by up to 6 keywords. The abstract should not contain any acronyms or abbreviations other than those generally accepted. If the article is accepted for publication, a Ukrainian translation of the abstract, the article title, initials and last names of all authors, departmental affiliation, and department heads where the work was performed will be required.

3. Text of the article

The approximate length of original articles should be 3-5,000 words, while review articles can be up to 7,500 words. The font should be Times New Roman 14, hyphenation should be turned off, and page size should be A4 210 ´ 297, with 2-cm margins.

Original articles should contain the following sections: Introduction, Materials and methods, Results, Discussion, and Conclusions. All abbreviations should be spelled out on first use, with the abbreviation in brackets, e.g. laparoscopic cholecystectomy (LC), with the abbreviation used thereafter.  All drugs should be referred to by their generic names; proprietary names are not to be used. All measurements should be reported in SI units, except for blood pressure, which is reported in mmHg. The International Anatomical and Histological Nomenclature and the International Classification of Diseases 10th revision should be used as appropriate. The names of equipment and drug manufacturers should be presented in the original language (without translation).

In experimental animal studies, the type of animal (according to the International Biological nomenclature), the sex and number of animals, methods of anesthesia used to reduce pain, and methods of euthanasia should be reported in accordance with local rules related to the use of experimental animals; authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed and that appropriate approvals were obtained.

Studies involving human subjects should indicate that the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2008, and that they obtained approval from the appropriate institutional review board or ethics committee, with all subjects providing their written, informed consent.

4. References

Authors are responsible for the accuracy of their references. References cited should be no older than 5 years and be connected directly related to the subject of the text. The number of references is limited to no more than 30 for original articles, 60 for review articles, and 15 for other types of articles. The references should be listed in order of citation in the text, not alphabetically.

Journal references should include: name and initials of all authors, title of article, abbreviated title of the journal (according to Index Medicus), year, volume, start and end pages according to the requirements of the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (Am Intern Med 1997, 126, 36-47.). Similarly, books should include the surname and initials of authors, title, name and city of the publisher, year, edition, first and last pages.

Authors should consult the following examples.

Journal articles:

1. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, Ross A: Exercise-induced ST depression in the diagnosis of coronary artery disease: a metaanalysis. Circulation 1989, 80, 87-98.

2. Duffy MJ: Tumor Markers - Which Ones Are Clinically Useful? Adv Clin Exp Med 2003, 12, 555-559.

Ukrainian and Russian journals:

1. Kotelevs'ka N.V. Justification of the method zaapekalnoyi therapy and acute purulent exacerbations of chronic apical periodontitis. Visnyk stomatologiyi 2004; 4: 30-33. Ukrainian: (Котелевська Н.В. Обґрунтування методу заапекальної терапії гострого гнійного та загостреного хронічного верхівкового періодонтитів. Вісник стоматолоґії 2004; 4: 30-33).

1. Baevskiy R.M., Ivanov G.G., Chireykin L.V. et al. Analysis of heart rate variability using different ECG systems (guidelines). Vestnik aritmologii 2002; 24: 65-86. Russian (Баевский Р.М., Иванов Г.Г., Чирейкин Л.В. и соавт. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). Вестник аритмологии 2002; 24: 65-86).

Book chapters:

1. Rossati ML, Smith R, Krovis BLK: Congestive Heart Failure. In: Heart Disease in Infants, Children, and Adolescents. Eds.: Moss AJ, Adams F, Williams & Wilkins, Baltimore 1983, 2nd ed., 169-179.

Ukrainian and Russian book chapters:

1. Belenkov Yu. N. Cardiomyopathies. In.: Chazov E.I., Belenkov Yu.N., eds. Rationale for drug therapy of cardiovascular diseases: A guide for medical practitioners. Moscow: Litterra Publishers; 2006. pp. 431-452. Russian (Беленков Ю.Н. Кардиомиопатии. В кн.: Чазов Е.И., Беленков Ю.Н., редакторы. Рациональная фармакотерапия сердечно-сосудистых заболеваний: Руководство для практикующих врачей. М.: Литтерра; 2006. с. 431-452).


1. Roobak AB: Textbook of Internal Medicine. Saunders, New York 1887, 24th ed., 123-127.

Ukrainian and Russian books:

1. Kuzminskij A.I. Pedagogy of higher school / A.I. Kuzminskij. – Kyiv.: Znannja, 2005. – 486 p. Ukrainian (Кузьмінський А.І. Педагогіка вищої школи / А.І. Кузьмінський. – К.: Знання, 2005. – 486 c.).

1. Shlyakhto E.V., Konradi A.O., Tsyrlin V.A. The autonomic nervous system and hypertension. SPb.: Meditsinskoe izdatel'stvo; 2008. Russian (Шляхто Е.В., Конради А.О., Цырлин В.А. Вегетативная нервная система и артериальная гипертензия. СПб.: Медицинское издательство; 2008).

Web sites should be included in the reference list, but not in the text. Links to Web sites should be used only when the original text is available, as follows:

WHO. Severe Acute Respiratory Syndrome (SARS). www.who.int/csr/sars/en/index.html. Дата останнього оновлення: June січня 2010. Дата останнього доступу: June жовтня 2010.

5. Figures and tables

Figures should be submitted in separate files (file name corresponding to the figure number) as jpg or tif files, with a resolution of at least 600 dpi, size 9 cm ´ 12 cm. Tables, charts, and graphs should be numbered, with titles placed after the references in the main text file, followed by the figure legends. Row and column labels of tables must match the data described in the text. Please indicate the statistical methods used. Formulas should be submitted in “Math Type”. Charts and Diagrams should be prepared using “Excel” in black and white using only hatching.

6. Author information

Information about each author must be submitted, including name, surname, position, scientific degree and title, address, phone, fax, and e-mail. One author should be identified as the corresponding author.

All sources of funding and all potential conflicts of interest should be identified for each author in a separate section prior to the references. If no conflicts of interest exist, this should be so stated.

7. The electronic version of the article

The editorial office accepts the electronic version of the article (file) on CD disk, which must be saves as an MS Word file. The file should be labeled according to the first author’s last name and noted on the cover of the disk.

8. Editing

Editors reserve the right to refuse publication of any article submitted and to edit articles according to house style as needed. If necessary, the article may be returned to the authors for proofreading and revision; it must be returned to the Editor within 3 days. The authors are solely responsible for the content and veracity of their articles. The editors will not return manuscripts and engage in scientific discussion and correspondence with the authors. The journal does not pay royalties to authors; submitted articles become the copyright of the journal, and reprinting is prohibited without permission of the publisher. Articles not prepared according to the above requirements will not be considered.

9. Submission

The original work and a paper copy should be initialed by all authors and be accompanied by an electronic version of the article on CD. The package of documents necessary to submit printed, completed and signed a "Declaration of Publication Ethics" and "Conflict of Interest Disclosure Form". 

All submissions should be addressed to:

The Editors,

Lviv Medical Journal / Acta Medica Leopoliensia

Danylo Halytsky Lviv National Medical University

Pekarska 69

79010, Lviv.


Journal contact info:

Tel. (032) 275-49-36.

e-mail: aml.lnmu@gmail.com

Summary of General Principles

1. The journal accepts articles in Ukrainian and English.

2. Each article will be reviewed by two independent reviewers.

3. The Editorial Board recommends publication after receiving positive reviews.

4. If reviewers have made comments, the author is given the opportunity to respond to the reviewers’ comments and make appropriate changes.

5. Authors must certify that the article has not been previously published and is not under consideration by any other journal.

6. The published article is copyright by Danylo Halytsky Lviv National Medical University.


Вимоги до подання

Під час подання рукопису до журналу автори повинні підтвердити його відповідність всім встановленим вимогам, вказаним нижче. В разі виявлення невідповідності поданої роботи пунктам цих вимог редакція повертатиме авторам матеріали на доопрацювання.

  1. Statement of Human and Animal Rights

    Research on Human Subjects

    For research involving human participants, written informed consent is mandatory, and all experiments and clinical investigations must be conducted according to the ethical standards given in the Declaration of Helsinki of 1975, as revised in year 2008.

    All research involving human subjects must be approved by the authors' institutional review board or appropriate committees (for example Ethic Committee Lviv National Medical University). The name of the board must be given in the manuscript.

     The manuscript should contain a statement in the Methods/Experimental section of the manuscript that: "All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008." and "Informed consent was obtained from all patients for being included in the study."

     Authors may be required to submit, on request, a statement from the institutional review board or research ethics committee indicating approval of the research. If a form was used to take written, informed consent from the patient included in the study, submit a sample of the patient consent form.

     If no human experiments were performed, omit the above statement and include the statement:

    "This article does not contain any studies with human subjects performed by any of the authors."


    Animals Studies and Ethical Treatment

     Studies involving experiments with animals must state that their care was in accordance with institution's or national research council's guidelines for, or any national law on the care and use of laboratory animals. All animal work must have been conducted according to relevant national and international guidelines. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated.

     Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand.

     The manuscript should contain a statement in the Methods/Experimental section of the manuscript that: "All institutional and national guidelines for the care and use of laboratory animals were followed."

    If animals experiments were not performed, omit the above statement and include the statement:

    "This article does not contain any studies with animal subjects performed by any of the authors."


Положення про авторські права

Declaration of Publication Ethics


As the author (the first author) of the article that is submitted for publication in “Lviv Medical Journal” I,___________________________, certify that research presents an accurate account of the work performed as well as an objective discussion of its significance. The data the research is based on are provided in my (our) article in sufficient amount.

I understand that the article submitted contains sufficient detail and references to permit others to replicate the work. Fraudulent knowingly inaccurate statements constitute unethical behavior and are unacceptable.


I acknowledge that I will submit all the data related to the article upon the request of the editorial board of “Lviv Medical Journal” for editorial review and guarantee to retain the aforementioned data at least for 2 years after publication.

I guarantee that work submitted is entirely original research and, if I have used the work or results of others that this has been appropriately cited or quoted.  

I realize that any form of plagiarism (submitting article of other author under my name, unauthorized copying or citation of parts of other articles) constitute unethical behavior and is unacceptable.

I know that I should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.

I know that authorship is limited to those who have made a significant contribution to the conception, design, execution or interpretation of the reported study. The first or corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

I am conversant that in case of discovering a significant error or inaccuracy in my published work I am obliged to promptly notify the editor or publisher and cooperate with the editor to retract or correct the article. If the editor would be informed by the third person that published paper contains an essential mistake, the author is obliged to promptly retract the paper or present to the editor proves of accuracy of the primary paper.

Date____________________ Signature of the first author __________________________

I, the Head of Ethic Board of the journal “Lviv Medical Journal”, Prof. Oleksandr D.Lytsyk, by my signature certify that the author of the article “_____________” that is submitted to the Editorial Board of the Journal, agrees with all the aforementioned statements of Declaration of Publication Ethics.

Date ____________________ Signature __________________________


Conflict of Interest Disclosure Form


All authors are expected to disclose to the readers any real or apparent conflict of interest that may have a direct bearing on the subject matter of the article. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services may be related to the subject matter of the article or who have sponsored the study.

The intent of the policy is not to prevent authors with a potential conflict of interest from publication. It is merely intended that any potential conflict should be identified openly so that the readers may form their own judgements about the article with the full disclosure of the facts. It is for the readers to determine whether the authors’ outside interest may reflect a possible bias in either the exposition or the conclusions presented.

The corresponding author will complete and submit this form.

Article Title__________________________________________________________



I certify that there is no actual or potential conflict of interest in relation to this article. If any conflict exists, please define hereafter:

Conflict (if none, “None” or describe financial interest/arrangement with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this article):


Name _______________________________________________________________

Signature _________________________Date_______________________________



Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 – Definitions.

  1. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
  2. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.
  3. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
  4. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
  5. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
  6. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
  7. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
  8. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
  9. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.
  10. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
  11. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
  12. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 – Scope.

  1. License grant.
    1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
      1. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and
      2. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.
    2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
    3. Term. The term of this Public License is specified in Section 6(a).
    4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
    5. Downstream recipients.
      1. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
      2. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
    6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).
  2. Other rights.

    1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
    2. Patent and trademark rights are not licensed under this Public License.
    3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 – License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

  1. Attribution.

    1. If You Share the Licensed Material (including in modified form), You must:

      1. retain the following if it is supplied by the Licensor with the Licensed Material:
        1. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
        2. a copyright notice;
        3. a notice that refers to this Public License;
        4. a notice that refers to the disclaimer of warranties;
        5. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
      2. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
      3. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
    2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
    3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
    4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 – Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

  1. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;
  2. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
  3. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 – Disclaimer of Warranties and Limitation of Liability.

  1. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
  2. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
  1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 – Term and Termination.

  1. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.
  2. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

    1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
    2. upon express reinstatement by the Licensor.
    For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
  3. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
  4. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 – Other Terms and Conditions.

  1. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
  2. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 – Interpretation.

  1. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
  2. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
  3. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
  4. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Положення про конфіденційність

Імена та електронні адреси, які вказуються користувачами сайту цього журналу, будуть використовуватись виключно для виконання внутрішніх технічних завдань цього журналу; вони не будуть поширюватись та передаватись стороннім особам.


ISSN: 2415-3303